142 related articles for article (PubMed ID: 30571357)
1. Prognostic Significance of Cardiac Magnetic Resonance Imaging Late Gadolinium Enhancement in Fabry Disease.
Hanneman K; Karur GR; Wasim S; Morel CF; Iwanochko RM
Circulation; 2018 Nov; 138(22):2579-2581. PubMed ID: 30571357
[No Abstract] [Full Text] [Related]
2. Guidelines for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging-Part 3: Perfusion, Delayed Enhancement, and T1- and T2 Mapping.
Im DJ; Hong SJ; Park EA; Kim EY; Jo Y; Kim J; Park CH; Yong HS; Lee JW; Hur JH; Yang DH; Lee BY
Korean J Radiol; 2019 Dec; 20(12):1562-1582. PubMed ID: 31854146
[TBL] [Abstract][Full Text] [Related]
3. Late gadolinium enhancement image masquerading as hypertrophic cardiomyopathy in Fabry disease receiving enzyme replacement therapy.
Yano T; Oshima H; Miki T; Tanaka M; Muranaka A; Osanami A; Takahashi F; Miura T
Int J Cardiol; 2016 Jan; 203():136-7. PubMed ID: 26512827
[No Abstract] [Full Text] [Related]
4. Prognostic Significance of Late Gadolinium Enhancement in Fabry Disease-A Systematic Review and Meta-Analysis.
Ricci F; Bisaccia G; Mansour D; Molinari LV; Di Mauro M; Renda G; Khanji MY; Gallina S
Am J Cardiol; 2023 Sep; 202():4-5. PubMed ID: 37406444
[No Abstract] [Full Text] [Related]
5. Letter regarding Morsbach et al. "Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy".
Ma H; Wang Y; Wang Y; Shi L; Zhang J; Wen Z; Chen L; Wang Z; Shi Y; Sun C; Pan Y; Liu J; Xie H; Yang J
Int J Cardiol; 2018 Apr; 256():35. PubMed ID: 29395363
[No Abstract] [Full Text] [Related]
6. Delayed Gadolinium Enhancement Magnetic Resonance Imaging Detected Anatomic Gap Length in Wide Circumferential Pulmonary Vein Ablation Lesions Is Associated With Recurrence of Atrial Fibrillation.
Linhart M; Alarcon F; Borràs R; Benito EM; Chipa F; Cozzari J; Caixal G; Enomoto N; Carlosena A; Guasch E; Arbelo E; Tolosana JM; Prat-Gonzalez S; Perea RJ; Doltra A; Sitges M; Brugada J; Berruezo A; Mont L
Circ Arrhythm Electrophysiol; 2018 Dec; 11(12):e006659. PubMed ID: 30562102
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of unrecognized myocardial infarction detected with MR imaging in patients with impaired fasting glucose compared with those with diabetes.
Yoon YE; Kitagawa K; Kato S; Nakajima H; Kurita T; Ito M; Sakuma H
Radiology; 2012 Mar; 262(3):807-15. PubMed ID: 22274838
[TBL] [Abstract][Full Text] [Related]
8. Myocardial lipid content in Fabry disease: a combined
Petritsch B; Köstler H; Weng AM; Horn M; Gassenmaier T; Kunz AS; Weidemann F; Wanner C; Bley TA; Beer M
BMC Cardiovasc Disord; 2016 Oct; 16(1):205. PubMed ID: 27793097
[TBL] [Abstract][Full Text] [Related]
9. Multimodality Imaging Assessment of Fabry Disease.
Tower-Rader A; Jaber WA
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009013. PubMed ID: 31718277
[TBL] [Abstract][Full Text] [Related]
10. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease.
Moon JC; Sheppard M; Reed E; Lee P; Elliott PM; Pennell DJ
J Cardiovasc Magn Reson; 2006; 8(3):479-82. PubMed ID: 16755835
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of unrecognized myocardial scar in the non-culprit territories by cardiac magnetic resonance imaging in patients with acute myocardial infarction.
Omori T; Kurita T; Dohi K; Takasaki A; Nakata T; Nakamori S; Fujimoto N; Kitagawa K; Hoshino K; Tanigawa T; Sakuma H; Ito M
Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):108-116. PubMed ID: 28950314
[TBL] [Abstract][Full Text] [Related]
12. Late gadolinium enhancement cardiac magnetic resonance imaging in prognostic assessment of hypertrophic cardiomyopathy.
Bouabdallaoui N; Ennezat PV; Durand E; Puymirat E; Macron L
Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):1024. PubMed ID: 23644935
[No Abstract] [Full Text] [Related]
13. Contrast-enhanced cardiac magnetic resonance imaging.
Restrepo CS; Tavakoli S; Marmol-Velez A
Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):739-60. PubMed ID: 23088948
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
Green JJ; Berger JS; Kramer CM; Salerno M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy.
Morsbach F; Gordic S; Gruner C; Niemann M; Goetti R; Gotschy A; Kozerke S; Alkadhi H; Manka R
Int J Cardiol; 2016 Aug; 217():167-73. PubMed ID: 27183453
[TBL] [Abstract][Full Text] [Related]
16. LGE and the risk of sudden death in HCM.
Alla VM; Koneru S; Hunter C; Mooss A
JACC Cardiovasc Imaging; 2012 Jul; 5(7):761-2; author reply 762-3. PubMed ID: 22789948
[No Abstract] [Full Text] [Related]
17. Prediction of functional recovery by cardiac magnetic resonance feature tracking imaging in first time ST-elevation myocardial infarction. Comparison to infarct size and transmurality by late gadolinium enhancement.
Buss SJ; Krautz B; Hofmann N; Sander Y; Rust L; Giusca S; Galuschky C; Seitz S; Giannitsis E; Pleger S; Raake P; Most P; Katus HA; Korosoglou G
Int J Cardiol; 2015 Mar; 183():162-70. PubMed ID: 25675901
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
19. Tei index in fabry disease.
Niemann M; Breunig F; Beer M; Hu K; Liu D; Emmert A; Herrmann S; Ertl G; Wanner C; Takenaka T; Tei C; Weidemann F
J Am Soc Echocardiogr; 2011 Sep; 24(9):1026-32. PubMed ID: 21719255
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of late gadolinium enhancement in cardiomyopathy: causative risk factor or surrogate marker?
Alter P; Figiel JH
Int J Cardiol; 2015 Feb; 180():111-3. PubMed ID: 25438229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
